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to promote the physical health of people with
mental health problems: a systematic review
A-La Park1*, David McDaid1,2, Prisca Weiser3, Carolin Von Gottberg3, Thomas Becker4, Reinhold Kilian4
and for the HELPS NetworkAbstract
Background: Recently attention has begun to focus not only on assessing the effectiveness of interventions to
tackle mental health problems, but also on measures to prevent physical co-morbidity. Individuals with mental
health problems are at significantly increased risk of chronic physical health problems, such as cardiovascular
disease or diabetes, as well as reduced life expectancy. The excess costs of co-morbid physical and mental health
problems are substantial. Potentially, measures to reduce the risk of co-morbid physical health problems may
represent excellent value for money.
Methods: To conduct a systematic review to determine what is known about economic evaluations of actions to
promote better physical health in individuals identified as having a clinically diagnosed mental disorder, but no
physical co-morbidity. Systematic searches of databases were supplemented by hand searches of relevant journals
and websites.
Results: Of 1970 studies originally assessed, 11 met our inclusion criteria. In addition, five protocols for other studies
were also identified. Studies looked at exercise programmes, nutritional advice, smoking, alcohol and drug
cessation, and reducing the risk of blood borne infectious diseases such as HIV/AIDS and hepatitis. All of the
lifestyle and smoking cessation studies focused on people with depression and anxiety disorders. Substance abuse
and infectious disease prevention studies focused on people with psychoses and bipolar disorder.
Conclusions: There is a very small, albeit growing, literature on the cost effectiveness of interventions to promote
the physical health of people with mental health problems. Most studies suggest that value for money actions in
specific contexts and settings are available. Given that the success or failure of health promoting interventions can
be very context specific, more studies are needed in more settings, focused on different population groups with
different mental health problems and reporting intermediate and long term outcomes. There is a need to better
distinguish between resource use and costs in a transparent manner, including impacts outside of the health care
system. Issues such as programme fidelity, uptake and adherence should also be accounted for in economic
analysis. The role of behavioural psychological techniques to influence health behaviours might also be considered.
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Protecting the physical health of people with mental disor-
ders is becoming more prominent in national and regional
mental health policies [1-3]. This policy interest comes at
a time when a growing number of studies have demon-
strated that people with mental disorders are more likely
to have costly co-morbid physical health problems than
would be seen in the general population [4-7]. Illness,
such as psychoses, bipolar disorder and major depression
increase the risk of diseases such as obesity, diabetes, car-
diovascular disease and chronic obstructive pulmonary
disorder [8,9].
Several factors can contribute to poor physical health.
Physical illness such as cardiovascular disease, diabetes
mellitus and chronic obstructive pulmonary disorder can
go under reported and under treated in people with men-
tal health problems [10-12]. Individuals may be reluctant
to come into contact with health care services for fear of
being labelled as having mental health problems, while
clinicians may not place enough emphasis on the manage-
ment of physical health and provide inadequate assess-
ment, monitoring and care. For instance, one previous
review reported that screening rates for metabolic syn-
drome in people with severe mental health problems
remains low [10]. Negative attitudes in some health care
professionals may also mean that some physical symptoms
are wrongly thought to be a symptom of mental illness
rather than an indication of a physical illness [13]. In one
recent survey of nearly 800 people living with schizophre-
nia in 27 European countries, 17% felt that they experi-
enced discrimination when treated for physical health
problems [14].
There may also be a lack of incentives in primary care
to monitor physical health problems, while the organisa-
tion of secondary health care systems in some countries,
where mental health services may be largely separated
from physical health services, can compound these issues,
making the provision of seamless care for both physical
and mental health problems more difficult to achieve. The
association between poverty and poor mental health may
also increase the likelihood that those with more severe
mental health problems may live in areas of socio-
economic deprivation, which could further impact on
their access to and utilisation of health care services
Poor lifestyle behaviours also remain critical contribu-
tory factors. This is particularly important given that there
may be adverse effects of some medications prescribed to
people with mental health problems. Rates of smoking in
people with mental health problems are typically much
higher than those seen in the general population. In one
English population survey, for example, 42% of all ciga-
rettes were smoked by people with mental disorders in
2007 [15]. Reviews covering a range of mental health
problems in different population groups in differentsettings have also highlighted lower levels of physical ac-
tivity, often combined with poor eating habits and nutri-
tional intake [16-22].
There may also be increased risks of communicable dis-
ease such as sexually transmitted infections, including
HIV/AIDS, as well as blood borne conditions including
hepatitis because of cognitive dysfunction, multiple casual
sex partners and unsafe needle sharing among some indi-
viduals who also have substance abuse problems [23,24].
The increased risk of homelessness, temporary accommo-
dation or living in institutional settings also compounds
the risks of both non communicable and infectious dis-
eases [25,26].
These and other co-morbid physical health problems in-
crease the risk of mortality compared with the general
population. This difference in life expectancy can be stark.
A study of men and women with severe mental disorders
in Denmark, Finland and Sweden reported that they lived
20 and 15 years less respectively than the general popula-
tion [27]. In an analysis of case registry data in London,
and compared with the general population, women with
schizophrenia, schizoaffective disorder or bipolar disorder
lost between 9.8 and 17.5 years of life, while men lost be-
tween 8.0 and 14.6 years [28]. Life expectancy was also
lower for individuals in this registry who were being
treated for depressive disorders – with a reduced life ex-
pectancy of 10.6 and 7.2 years for men and women com-
pared to the general population. Using data from the UK
General Practice Research Database on 46,000 people with
severe mental illness, Osborn and colleagues also reported
a threefold difference in risk of cardiovascular deaths for
those between 18 and 49 and an almost twofold increased
risk for those aged 50–75 [29].
There is also evidence to suggest that inequalities in all
causes of mortality risk appear to have widened between
those with severe mental health problems and the general
population. One meta-analysis looking at schizophrenia
reported a significant increase in standardised mortality
ratios using data from twenty-five countries over the
period from 1980 to 2006, despite the increased availabil-
ity of medications that can help individuals better manage
mental health problems [30].
Co-morbidity has also been associated with substantially
increased economic burden. It compounds the adverse
impacts of mental illness with excess costs for the treat-
ment for physical health problems [31-37]. It can also in-
crease the likelihood that individuals will not be able to
participate in the labour force, education or look after
their families.
All of these factors emphasise the importance of identi-
fying effective approaches to promote and protect the
physical health of people with mental health problems,
taking into account behavioural, environmental and iatro-
genic health risks [38]. Recent reviews indicate an
Park et al. BMC Public Health 2013, 13:787 Page 3 of 17
http://www.biomedcentral.com/1471-2458/13/787increasing literature on clinical effectiveness studies of in-
terventions to promote physical health and/or treat co-
morbid physical health problems in people with mental
health problems [39-42].
Potentially measures that are effective in reducing the
risk or consequences of co-morbid physical health prob-
lems may represent excellent value for money. While
there has been some economic analysis of interventions to
promote and protect mental health [43], to date compara-
tively little attention appears to have been paid to the cost
effectiveness of physical health promoting interventions
for this population. Given that health care budget holders
have to make difficult choices on how to allocate scarce
resources to mental health and other services, it is crucial
to know whether any investment in interventions/pro-
grammes to prevent physical health problems in people
with mental health problems represents a worthwhile ac-
tion. What, for instance, are the consequences for resource
use in both the health care and related sectors?
Objectives
Given the importance of this topic the aim of this paper is
to conduct a systematic review to identify economic evalu-
ations of interventions intended specifically to promote
better physical health and/or prevent physical health prob-
lems in people with clinically diagnosed mental disorders.
To date only one review appears to have included eco-
nomic considerations in this area; focused on the effec-
tiveness of psycho-educational, behavioural/exercise/diet
modification interventions for people with severe mental
disorders it was unable to find any cost-effectiveness
studies [41].
Methods
A detailed review protocol for this analysis is available
from the corresponding author on request. This has been
developed in line with the established Preferred Repor-
ting Items for Systematic Reviews and Meta Analyses
(PRISMA) reporting guidelines [44]. A PRISMA checklist
is also provided in Additional file 1.
Inclusion and exclusion criteria
Types of participants
Human participants of any age from studies taking place
in high income countries. These studies needed to look at
individuals with a primary diagnosis of moderate or severe
mental illness, including schizophrenia, bipolar disorder,
moderate and major affective disorder and delusional dis-
order. We only included individuals with alcohol or sub-
stance abuse disorders where these were part of a dual
diagnosis with one of these mental health problems. We
also excluded diagnoses of Alzheimer’s Disease and related
disorders, eating disorders and intellectual disabilities,
from our analysis.As our focus here was on disease prevention and health
promotion; we excluded studies that looked at the
economic benefits of treating physical health problems in
people with pre-existing mental and physical co-mor-
bidities. Nor did we look at the economic literature on in-
terventions to prevent mental health problems in people
with chronic physical illness such as diabetes or cardiovas-
cular disease. There were no other restrictions on socio-
economic or clinical characteristics.
Types of intervention
Any non pharmacological interventions specifically tar-
geted at promoting the physical health of individuals living
with mental health problems. Interventions could for in-
stance include exercise programmes, nutritional advice,
smoking, alcohol and drug cessation and infectious dis-
eases prevention. Our analysis was restricted to interven-
tions delivered in countries defined by the World Bank as
being high income.
Types of outcome measure
We included all of the standard economic evaluation
methods that have been defined in health economics [45].
In brief, all measure costs in the same way but differ in
how they measure economic outcomes. Cost-effectiveness
(CEA) and cost-consequences (CCA) analyses report out-
comes using natural clinical units e.g. changes in symptom
free days; cost-utility analyses (CUA) studies measure out-
comes in a common metric either in terms of quality or
disability adjusted life years gained; while cost-benefit
analyses (CBA) elicit monetary values from the public for
different health outcomes. In addition we also included
cost-offset analyses (COA), which highlight the potential
resource savings of an action without reporting on changes
in health outcomes. Studies that looked at economic in-
centives such as monetary rewards or changes in the price
of goods to promote behaviour change were also included
within the scope of our review.
Types of study
All of the economic evaluations described above that
bring together cost data with outcome data were eligible
for inclusion regardless of whether they were performed
prospectively alongside a controlled trial or other quasi-
experimental study design or retrospectively using data
from a previous effectiveness study. Economic modelling
studies that estimated the potential cost effectiveness of
interventions by synthesising evidence from trials and
other data sources on effectiveness and costs were also eli-
gible. We also recorded study protocol papers reporting
current evaluations in order to help identify the current
interest in this area, and the way in which the evidence
base is likely to develop further.
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We designed detailed specific systematic search strategies
for several health and social science bibliographic databases:
PubMed, PsycINFO, CINAHL, Francis, SocIndex and
EconLit, covering the period January 1990 to December
2012, with searches run for the period until June 2012 on 7
September 2012, and updated searches for the final six
months of the 2012 run on 2 January 2013. Our search
strategy for the PubMed database is provided in Additional
file 2 as an example of search strategies used. We combined
a wide range of phrases for mental disorders with health
promotion and public health terms along with terms for
economic evaluations and/or specific economic terms /
phrases such as cost-benefit. Papers could be in any lan-
guage, but they needed to have an English language abstract
to be potentially eligible for inclusion.
Our electronic search was supplemented by hand-
searches of a small number of relevant journals. A lim-
ited search of Google Scholar was also undertaken,
alongside scrutiny of relevant websites including think-
tanks, university economic research groups and some
government departments. We also looked at actual ex-
amples of programmes and guidelines for the promotion
of physical health that were identified separately within
our project [39].
References were initially imported into Endnote X5 and
duplicates eliminated. Remaining references were initially
checked independently by two reviewers, based on their
title and abstract to decide if they met our inclusion cri-
teria. In the case of disagreement, further discussions
about inclusion/exclusion were made. Full texts of poten-
tial matching articles were retrieved and then assessed to
determine whether they looked at both the costs and ef-
fectiveness of interventions Articles were excluded if full
texts did not provide cost or resource data. Data on biblio-
graphic information, the intervention and comparator,
duration of study, target population, economic evaluation
methods used, empirical study design, cost and resource
findings, effectiveness results and synthesis of costs and
effects were then extracted from eligible studies into a be-
spoke Excel data extraction form. We conducted a narra-
tive analysis and review of these studies. We did not plan
or conduct statistical meta-analysis or other formal, aggre-
gative synthesis of the results of included studies. All costs
were converted to 2010 International Dollars, as well as
being reported in their original currency and price year in
Table 1.
Results
As Figure 1 indicates, our search process resulted in 1970
references being identified. 50 articles were subsequently
retrieved based on the relevance of their abstracts. Of
these, six were excluded as they focused on interventions
to improve co-morbid mental disorders for people withpre-existing physical disease, which was outside the scope
of our current review. 27 studies which initially appeared
to be relevant were eventually excluded as no actual de-
tailed costing and resource use was reported and another
was excluded because of a lack of information on any
comparator group. This left 11 completed studies which
are summarised in Table 1. Table 2 summarises informa-
tion on a further five protocol papers for ongoing or
planned economic evaluations that were identified and
which should meet our inclusion criteria when completed.
Of completed studies seven were from the USA, with
three from the UK and one from Spain. Seven studies fo-
cused on psychosis and/or bipolar disorder. Three of these
studies focused on interventions to tackle substance
misuse and its consequences in people with dual diagno-
sis, while four reported on infectious disease reduction
strategies. The remaining four studies focused predomin-
antly on people with depression and/or anxiety disorders,
looking at lifestyle modification interventions in terms of a
smoking cessation programme, as well as three pro-
grammes focused on the promotion of physical activity.
Looking at the type of economic evaluation technique
used, five studies were cost-consequences analyses, with
five cost-utility analyses and one cost-effectiveness analysis.
No cost benefit analyses were identified. Eight of these eco-
nomic evaluations were performed prospectively alongside
randomised controlled trials. One of two retrospective
studies used a non-randomised quasi-experimental study
design to look at the adoption of the rehabilitative treat-
ment facilities for military veterans [46]. Two studies ex-
plored the costs and benefits of treating co-morbid HIV
infections by making use of modelling techniques [47,48].
We now look at these studies in more detail.
Lifestyle-based interventions to promote physical health
One key concern focuses on promoting a sustained in-
crease in physical activity and improved nutrition among
people with mental health needs. We identified three
studies looking at different physical activity interventions.
One Spanish study evaluated a walking-based, supervised
exercise programme for low-income older women with
moderate depression and/or obesity [49]. 55 women were
randomly allocated to a 50 minute supervised walking
programme, three times per week for six months, in
addition to dietary advice plus best primary care alone,
compared with 51 women receiving usual primary care
and a recommendation to exercise. Outcomes examined
included changes in mean Body Mass Index (BMI) and
changes in quality of life. After six months mean BMI de-
creased from 29.7 to 29.4 in the walking group, but in-
creased from 30.6 to 30.8 in the usual care group
(p<0.003). Supervised walking was highly cost effective at
$449 (€311, 2005 prices) per QALY gained, with a 99.9%
probability of being cost effective assuming a cost per
Table 1 Economic evaluations alongside empirical studies for interventions promoting physical health for people with mental health problems
Author,
Year of
Publication,
Country of
Study
Intervention (I) Target Population Study Design
Type of analysis
Summary of main
resource and cost results
Physical health related
effectiveness results
Perspective/
Price year
Synthesis of costs
and effectsComparator (C) Duration of study
Barnett et al.
2008 [55]
I: Stepped smoking
cessation programme
(computer-assessments of
quit readiness; 6 weeks
psychological counselling,
10 weeks nicotine
replacement therapy;
bupropion,extra
counselling.
322 cigarette smoking
mental health out-patients
aged 18+ with a diagnosis
of unipolar depression
RCT The mean costs of
intervention were $346.
Total mental health care
costs in the intervention
and control group were
$4805 vs $4173. This
difference was not
significant.
The stepped care group
had 5.5.% greater
abstinence rate from
smoking.(p-value <0.05)
Health care
sector
Incremental cost per
successful quit $11,496.
Incremental cost per life year
gained $9,580. Cost effective
74% of time if WTP per
successful quit $40,000 .
USA
C: brief contact:
information on quitting
and list of cessation
programmes from
counsellor.
18 months CEA 2003 US $
Chalder et al.
2012 [51]
I: Primary care facilitated
physical activity plus usual
primary care physician care
361 community dwelling
individuals aged 18-69 with
first or recent new episode
of depression (>= 14 on BDI
scale)
RCT Mean health and social
costs per participant in the
intervention group were
£39 greater, but this was
not significant. The mean
costs of the intervention for
treatment completers were
£252. Productivity losses
were greater in the
intervention group and this
difference was almost
significant at p=0.05 level
Significantly greater amount
of physical activity at 12
months in intervention
group Odds Ratio 2.27
p=0.0003.
Health care
sector
perspective
only
Incremental cost per QALY
gained of £20,834. 57%
probability of being cost
effective with WTP threshold
of £30,000 per QALY gained.
Not considered likely to be
cost effective.
England, UK
Small but non significant
QALY gain of 0.014.
C: Usual primary physician
care only
12 months CUA 2009 UK £
Craig et al.
2008 [58]
I: Integrated management
of mental and substance
abuse disorders by
specially trained case
managers in community
mental health teams
(CMHTs).
127 community dwelling
mentally ill patients with
comorbid substance use
disorders treated by 40
specially trained and
supervised case managers
in CMHTs and105
community dwelling
patients receiving usual case
management from 39 case
managers in CMHTs.
RCT Total mean costs in the
intervention and control
groups were £18,672 and
£17,639. This difference was
not significant.
No impact on substance
use levels between the
groups at 18 month follow
up, but small positive
impact on mental health
status
Health care
and criminal
justice sectors
No synthesis was reported
as there was no significant
difference in costs or
substance abuse levels
between the two groups.
UK
C: Standard case
management in CMHTs
18 months CCA 2004 UK £
Gusi et al.
2008 [49]
I: Primary care initiated
supervised walks with a
group in a park or forest
tracks for 50 minutes, 3
127 overweight, moderately
obese or moderately
depressed community
dwelling older women.
RCT The incremental cost of the
exercise programme plus
best care, relative to best
care was €2250.
Body Mass Index (p<0.003) Health care
sector
Incremental cost per QALY
gained: €311. 99.9%
probability of being cost
effective if WTP of just €600
per QALY gained.
Spain Exercise: 29.7->29.4
Control: 30.6-> 30.8.
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Table 1 Economic evaluations alongside empirical studies for interventions promoting physical health for people with mental health problems (Continued)
times per week plus simple
diet advice.
The mean incremental
Quality Adjusted Life Years
gained was 0.132 (95%
CI:0.104-0.286)C: The standard 6 months CUA 2005 €
“best primary care” :
routine care in general
practice and a
recommendation of
exercise
Johnson-
Masotti et al.
2000 [48]
Two interventions: Community dwelling
people with severe mental
illness being treated on an
outpatient basis at risk of
HIV.
Modelling The total costs of
intervention include staff
compensation, materials,
transportation, overhead,
and participants’
opportunity costs. Average
cost per person:
Infection averted per 100
clients
Societal Advocacy training group (A)
was most cost effective for
men with incremental cost
per QALY gained of $48,585.
For women single session
intervention is cost saving
I: A multi-session small
group intervention (M) Men
USA I: Advocacy training (multi-
session that taught
participants to act as safer
sex advocates to their
peers).(A)
Single session: $178 S: 0.041
Multi-session: $629 M: 0.087
Advocacy training: $786 A: 0.138
Women
S:0.098
M: -0.041
A: 0.019
QALY gains not
documented
C: A single session, one-on
-one HIV/AIDS education
intervention (S)
3 months CUA 1998 US $
Morse et al.
2006 [59]
Two interventions 149 homeless people
treated on an outpatient
basis having a wide range
of severe mental illness with
substance disorder (i.e. dual
disorder diagnosis).
RCT The mean total costs for the
IACT ($48,764) and control
group ($41,726) were
significantly less than those
for the ACTO group ($71,211)
(p<0.05).
There were no differences
between treatment groups
in substance use.
Health care Costs and outcomes were
separately reported.
I: Integrated Assertive
Community Treatment
(IACT)
USA
I: Assertive Community
Treatment Only (ACTO)
C: Standard care 24 months CCA 2001 US $
Murphy et al
2012 (early
online) [50]
I: 16 week tailored
programme of exercise
delivered in a leisure
centre supervised by a
qualified exercise
professional. Plus
subsequent 8 month
2,160 community dwelling
sedentary individuals having
coronary heart disease
(CHD) risk, and/or mental
health problems (mild
anxiety, depression/ stress
disorders)
RCT Incremental cost for the
mental health or mental
health plus CHD group was
£596 but this was not
significant. There was a
small significant
improvement of 0.0058
QALYs gained in this group.
CHD group reported
significantly higher levels of
physical activity, but no
difference for those referred
wholly or partially for
mental health reasons. The
mental health group did
have statistically significant
Public sector Incremental cost per QALY
gained for whole population
£12,111. 89% probability of
being cost effective at
£30,000 per QALY gained.
£10,276 per QALY gained for
mental health or mental
health and CHD group.
Wales, UK
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Table 1 Economic evaluations alongside empirical studies for interventions promoting physical health for people with mental health problems (Continued)
telephone contact by
exercise professional.
improvement in
depression/anxiety.
C:Usual care plus
information on benefits of
exercise and location of
local facilities
12 months CUA 2009 UK £
Pinkerton
et al. 2001
[47]
I: Small group HIV
prevention programme in
community mental health
clinics, focusing on sexual
communication, condom
use skills, and motivation
to practice safer sex.
87 community dwelling
women at least being 18
years old with a psychiatric
diagnosis of mental illness.
Modelling Intervention cost per
participant: $679. Saved
$13,830 in HIV-related
medical care costs. The cost
per 100 women was
$67,910, a net cost of
$54,080 costs avoided in
medical care costs. For
sexually active women only,
there were $22,284 in
avoided medical care costs
per 100 women.
For full sample, intervention
averted 0.064 infections and
saved 0.40 QALYs. For
sexually active women only,
0.104 infections were
averted and 0.64 QALYs
saved.
Societal For full sample, cost per
QALY saved: $136,295.
USA For sexually active women
only, $71,367 per QALY
saved.
C: Standard health
promotion programme
without inclusion of HIV
6 months CUA 1999 US$
Rosenberg
et al. 2004
[60]
I: Specialist brief
programme delivered in
community mental health
centres to reduce risk of
blood borne infectious
disease.
173 community dwelling
people with serious mental
illness
A ‘before and
after’ pilot study
at one urban
and one rural
community
mental health
centre
Intervention costs per
person ranged between
$194 and $262.
Increased motivation to
reduce risk behaviour such
as HIV and hepatitis
(p<0.01). But no actual
decrease in self-reported
risk behaviour.
Health care Concluded that pilot study
supports feasibility and
efficacy of intervention.
USA
C: No controls – change in
knowledge and risk
behaviours post
intervention
6 months CCA 2002 US $
Rosenberg
et al. 2010
[61]
I: Specialist brief
programme delivered in
community mental health
centres to reduce risk of
blood borne infectious
disease
236 community dwelling
people with severe mental
illness and co-occurring
substance use disorder
largely from ethnic minority
groups.
RCT Intervention cost per
person: $541 including $234
for blood tests.
People in the intervention
group were more likely to
be tested for HBV and HCV ,
and immunised against
hepatitis A and hepatitis B,
to reduce their substance
abuse. However, they
showed no decrease in risk
behaviour.
Health care Costs and outcomes were
separately reported.
USA
C: Enhanced treatment as
usual.
12 months CCA US $
Timko et al.
2006 [46]
I: Community residential
facility acute support
programme for dual
disorder people
57 community dwelling and
173 hospital with dual
psychiatric disorder and
substance abuse diagnosis
RCT Mean health care costs for
the community group were
$21,966 compared with
$33,188 in the hospital
group. This difference was
not significant.
The community group had
significantly improved
Addiction Severity Index
Scores compared to the
hospital group. 26% of the
community group were in
remission compared with
16% of the hospital group.
This was not significant
Health care Costs and outcomes
reported separately, but
noted that mean costs for
patients in remission in
community group of
$12,174 were less than half
those of hospital group.
USA
C: Hospital inpatient acute
support programme for
dual disorder people
12 months CCA For those patients
successfully in remission
from substance abuse cost
2003 US$
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 Literature search flow chart
1970 references retrieved from 
electronic bibliographical databases, 
hand search and Google search
Total of 2035 reference including 
duplicates
50 full text references retrieved
1940 unique abstracts screened
95 duplicate references excluded
1890 references excluded
11 completed studies and 5 protocol 
papers included in review
34 references excluded
No actual cost reported: n=27
Promotion/treatment of mental 
illness for people with pre-existing 
physical disease: n=6
No comparator group: n=1
65 programmes and guidelines 
Figure 1 Literature search flow chart.
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QALY gains may be conservative if the increased level of
physical activity can be maintained over the longer term.
In Wales the National Exercise Referral Scheme has
also been subject to economic evaluation [50]. Sedentary
individuals aged 17 or older with coronary heart disease
risk factors and/or mild anxiety, depression or stress
were randomised to receive a 16 week tailored exercise
programme delivered by exercise professionals using
motivational interview techniques to encourage the long
term sustainability of behaviour change. During this time
and for the subsequent eight months they were followed
up by phone by the exercise professional to help reduce
the risk of relapse. The intervention was found to signifi-
cantly increase physical activity in those with coronary
risk only; it did not have an impact on physical activity
in those with mental health problems, although there
were significant reductions in their depression or anxiety
status, suggesting that they may have benefited from so-
cial contact arising from participation in the scheme.
The cost per QALY gained for the mental health group
was $15,808 (£10,276, 2009 prices) compared with$18,631 (£12,111, 2009 prices) for the whole mental
health and coronary heart disease risk group. There was
an 89% of being cost effective for the whole study popu-
lation with a cost per QALY threshold of $46,150
(£30,000, 2009 prices).
A smaller scale randomised controlled trial looking at
professionally facilitated physical activity for people with
depression compared to usual primary care was under-
taken in England [51]. While the central aim was to look
at the impact of exercise on depression, for which no im-
pact was found, the study reported that the rate of
sustained physical activity in the intervention group was
more than double that of the control group at 12 month
follow up. This finding is important given the challenges
in motivating people with depression to engage in physical
activity. Therefore while the intervention was not consid-
ered to be cost effective as an intervention to tackle de-
pression, with little impact on recorded QALY outcomes
during the lifetime of the study, the intervention may have
potential in the longer term to be cost effective, if the in-
crease in physical activity in this population group can be
sustained and further benefits to physical health realised.
Table 2 Protocol papers for current economic evaluations
Bibliographic
information
Intervention (I) Target Population /Duration Study Design
Type of analysis
Cost results Physical health
related
Effectiveness
results
Perspective
/Price year
Synthesis
of costs
and effects
Comparator (C)
Bonevski et al.
2011 [57]
I: Client centred, caseworker-delivered
cessation support intervention for a
socially disadvantaged population.
200 community dwelling socially
disadvantaged smokers including
people with mental health
problems attending a community
social service centre
RCT Resources and costs of
interventions and impacts
on health service use
Changes in smoking
behaviour
Health
system only
Not stated
Australia
C: Information on smoking cessation and
telephone number for Quitline
12 months CCA
Carter et al.
2012 [52]
I: 12 week preferred intensity aerobic
exercise, with motivational coaching and
support
Community dwelling people
aged 14-17 already in contact
with health care services with
depression
RCT plus focus
group analysis
Boundaries not stated but
will use Client Service
Receipt Inventory to record
health care service use.
Changes in
depression using
Children’s
Depression Inventory
Not stated Incremental
cost per
QALY
gainedEngland, UK
QALYs using EQ-5D
C: Usual care 9 months CUA, CEA Physical Activity
Intensity (Borg Scale)
Kruisdijk et al.
2012 [54]
I: 6 months exercise therapy or Nordic
walking plus usual care
People aged 18-65 with diagnosis
of depression or bipolar disorder
who are being treated on an
inpatient or outpatient basis
RCT Resource use and costs
determined using Trimbos/
iMTA Questionnaire for
Costs associated with
Psychiatric Illness (TIC-P)
Risk factors for
metabolic syndrome.
Fitness and Physical
Activity. QALYs using
EQ-5D
Health care
use and
productivity
losses
Incremental
cost per
QALY
gainedThe
Netherlands
C: Usual care 12 months CUA
Stockings et al.
2011 [56]
I: Multi-modal smoking cessation
intervention (brief motivational
interviewing plus range of post discharge
support for up to 16 weeks.
200 smokers aged 18+ in an
inpatient facility with acute
mental health problems
RCT Resource use and costs
needed to deliver
intervention
Changes in smoking
behaviour. Use of
alcohol and other
substance abuse.
Mental wellbeing
Health
system only
Not stated
Australia
C: Hospital smoking care only includes a
referral to Quitline on discharge.
6 months post discharge CCA
Verhaeghe
et al. 2012 [53]
I: 10 week health promotion intervention
(psycho-educational and behavioural
group sessions, supervised exercise,
individual counselling) targeting physical
activity and diet plus usual care
People aged 18 – 75 with mental
disorders living in sheltered
housing. 201 in intervention; 83
in control group 9 months (RCT)
Cluster RCT and
Markov Modelling
to extrapolate risk
of CVD and
diabetes over 10
years
Intervention costs plus
costs of health care
utilisation
BMI, Waist
Circumference, body
weight, fat mass,
QALYs using SF-36
Health
system
Incremental
cost per
QALY
gainedBelgium
C:Usual care 10 years (model) CUA
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tions will grow as we also identified three protocol papers.
In England a published protocol describes an economic
evaluation alongside a trial of self-determined intensity
one hour per week for 12 weeks aerobic exercise pro-
gramme for community dwelling people aged 14–17 with
depression [52]. Two of the protocols will consider people
either in residential or inpatient settings. One is for a cost
utility analysis alongside a cluster randomised controlled
trial comparing the use of a ten week health promotion
programme versus usual care for people with a range of
mental health problems living in sheltered housing in
Flanders, Belgium [53]. The programme, which is being
delivered to more than 200 people, includes group-based
educational sessions, supervised exercise and individual
counselling. While empirical data will only cover a six
month follow up period, modelling will be used to
estimate the impacts of sustained behaviour change on
risks of cardiovascular disease and diabetes over a ten year
period.
The second study in the Netherlands is for a con-
trolled trial on the use of regular hour=long running
therapy or Nordic walking programmes over six months
by people of working age with depression or bipolar dis-
order being treated on an inpatient or outpatient basis
[54]. Impacts on metabolic risk factors, physical activity
rates and mental health will be assessed over one year.
All three of these studies will measure several outcomes
including incremental costs per QALY gained.
Programmes to reduce smoking, alcohol and
substance abuse
Another key concern is to tackle addictive behaviours such
as smoking, alcohol and illicit substance abuse in people
with mental health problems. However we were only able
to identify one cost effectiveness study looking specifically
at smoking cessation interventions for people with mental
health problems. This study compared a stepped cessation
programme (three computer-mediated assessments of
readiness to quit smoking, six psychological counselling
sessions, up to ten weeks nicotine replacement therapy,
and offer of sustained-release bupropion and two additional
counselling sessions) in outpatient care settings with brief
care for smokers with depression [55]. After 18 months the
stepped care group had a 5.5% greater chance of ceasing
smoking (P<0.05) at a cost per quit of $13,519 ($11,496,
2003 prices) or $11,266 ($9,580, 2003 prices) per life year
gained. In sensitivity analysis, applying a cost effectiveness
threshold of $40,000 per successful quit, there was a 74%
chance that the smoking cessation programme would be
cost effective.
We also identified two study protocols from Australia
related to smoking cessation interventions. One is looking
at the integration of multi-modal smoking cessationstrategies at an Australian inpatient facility and post-
discharge, including an analysis of cost impact [56]. The
second will evaluate the effectiveness and cost conse-
quences of smoking cessation advice provided to socially
vulnerable smokers, including those with mental health
problems, at a community social services centre [57].
We also identified studies looking at the economic case
for tackling the harmful effects on health of substance use
in individuals with a dual mental disorder / substance
abuse diagnosis. In south London, one evaluation looked
at the costs and effectiveness of an integrated care
programme using case managers trained to deal with sub-
stance use disorders in people with severe mental illness
[58]. After 18 months, no significant differences in costs,
alcohol consumption or cannabis use were observed be-
tween the integrated care group and waiting list controls.
A lack of continuity in case management due to high staff
turnover, diverting resources to staff retraining and reten-
tion mechanisms may have hampered the intervention,
while the duration of the study was also felt by the authors
not to be long enough to achieve significant changes in
substance use.
In the USA, a small study with 149 participants also ex-
plored costs and outcomes of integrated treatment for
both mental health needs and substance abuse by the
health care team plus Assertive Community Treatment
(IACT), compared with Assertive Community Treatment
Only (ACTO) or standard care (SC) for homeless people
with a dual diagnosis [59]. While the study reported no
significant difference in substance abuse or mental health
outcomes, the IACT and ACTO groups were significantly
more likely to be in stable housing (P=0.03); they were
also significantly more likely to be satisfied with their care
(P=0.03). Over 24 months, IACT and SC had significantly
lower costs than ACT (p value not reported). The ACTO
group’s costs may have been higher because they did not
follow their own protocol and made much use of external
outpatient mental health services rather than using their
own team psychiatrist.
Another randomised controlled trial from the US evalu-
ated costs and outcomes for 230 people with a dual
diagnosis of co-morbid substance use and psychiatric dis-
orders initially assigned to either a hospital or community
residential facility (CRFs) acute care programme [46].
Over one year, patients in the CRF group had Addition
Severity Index (ASI) scores that were significantly lower
for both alcohol use (p<0.01) and drug use (P<0.05) com-
pared to the hospital group. Patients with moderate psy-
chiatric disorder severity showed better ASI scores for
alcohol use in CRFs (p<0.05), however patients with the
highest levels of severity had better outcomes in the hos-
pital group, although this difference was not statistically
significant. While there was no statistically significant dif-
ference in overall health care costs between the groups,
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costs in the CRF group were $14,317, ($12,174, 2003
prices) which was just over half the costs of similar pa-
tients in the hospital care group. While acknowledging
that these results should be interpreted with caution due
to small sample size, the authors suggested that shifting
more patients with less severe disorders away from hos-
pital care to community-based care could potentially lead
to cost-savings, especially if in addition to a reduction in
substance abuse other beneficial aspects of community
care in terms of its less restrictive nature and promotion
of social inclusion, were also considered.
Programmes to reduce the risk of infectious disease
People with dual diagnosis in particular are more likely
to be exposed to infectious disease such as HIV/AIDS,
hepatitis B and hepatitis C. Four economic studies of in-
terventions to reduce the risk of infectious disease were
also identified. Some were targeted at high risk popula-
tions such as people with both severe psychiatric disor-
ders and substance abuse.
The costs and outcomes of the brief STIRR (Screen,
Test, Immunise, Reduce risk, and Refer) intervention de-
livered by a mobile specialist team to prevent or detect
and treat blood-borne diseases in people with serious
mental health problems have been evaluated. Initially an
uncontrolled pilot study in two community mental
health centres in New Hampshire [60] reported signifi-
cant improvements in the levels of knowledge about
blood-borne infectious diseases (p<0.01) and in motiv-
ation for prevention before and after the intervention
(p<0.01), but no decrease was found in self-reported risk
behaviours. The cost of the programme ranged from
$233 to $315 ($194 to $262, 2002 prices) per participant.
Subsequently the costs and outcomes of the programme
were assessed in a randomised controlled trial delivered
to a dual diagnosis urban population [61]. Compared
with enhanced treatment as usual, there were modest
significant positive changes in the DALI (Dartmouth
Assessment of Lifestyle Instrument) scores for alcohol
use (p<0.022). Moreover, the STIRR group showed
significant improvements in clinician-rated Drug Use
Scale scores (p<0.034). However, there were no signifi-
cant changes in HIV knowledge or in risky behaviours.
Programme costs per participant were $551 ($541, 2008
prices) per participant (2008 US$). However, the costs of
care as usual, as well as any consequent impacts related
to health care resource utilisation were not reported.
In the US, Johnson-Masotti et al. performed a cost-
utility analysis of three cognitive-behavioural HIV/AIDS
risk reduction interventions for people with severe mental
illness, synthesising data using mathematical modelling
for a three-month period [48]. The interventions were a
single session (one-on-one) HIV education intervention, amultiple-session small group intervention, and a multi-
session group intervention for teaching peer advocacy
skills. Gender differences were observed in interventions
that were most cost effective, with advocacy training for
men having an incremental cost per QALY gained com-
pared to a single session intervention of $62,875 ($48,585,
1998 prices) a figure that would be considered cost effect-
ive in a US context. For women, while the single session
intervention was actually cost saving compared to doing
nothing, the multi-session intervention was less effective
at higher cost, while investing in advocacy training would
not have been cost-effective at an incremental cost of
$603,062 ($465,994, 1998 prices) per QALY gained.
Another US study looked at the cost-effectiveness of a
nine session small-group intervention to prevent HIV-
infection in women with mental disorders [47]. It sug-
gested that a targeted approach may be more cost effective
than a population wide strategy. For the whole study
population a cost per QALY gained of $173,828 ($136,295,
1999 prices) was seen, compared with a cost per QALY of
$91,020 ($71,367, 1999 prices) for high risk women, who
had been sexually active in the previous three months. Al-
though still well above the often suggested threshold value
of $50,000 per QALY gained in the USA [62], there may
have been potential for an even more targeted strategy to
be cost effective.
Discussion
There is a growing body of clinical effectiveness studies on
programmes to prevent somatic diseases in people with
mental disorders [39-42,63,64]. We have also indicated
that the importance of protecting physical health is to be
found in different mental health policy plans. While there
is an evidence base on the cost effectiveness of many
health promoting interventions for the general population,
our review indicates that there is still very little informa-
tion available on the cost-effectiveness of these interven-
tions for people with pre-existing mental health problems.
One previous review found no cost-effectiveness stud-
ies of lifestyle interventions on the physical activity and
eating habits of people with severe mental disorders [41],
while a recent Cochrane review was unavailable to find a
single randomised controlled trial reporting evidence on
the effectiveness or cost effectiveness of guidelines advis-
ing on the monitoring of physical health in people with
severe mental health problems [65]. Similarly a review of
programmes to promote the physical health of people
with mental health problems was only able to find some
brief information on the commercial costs of obtaining
manualised programmes rather than any evidence of
their cost effectiveness [39].
Smoking cessation has also been highlighted as a key
goal for the protection of physical health in people with
mental health problems, given the higher rates of smoking
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tion [66]. While there is an extensive literature on the cost
effectiveness of different smoking cessation strategies for
the general public, indicating that highly cost effective
smoking cessation interventions are available [67,68], we
were only able to identify one economic evaluation of a
smoking cessation study targeted at people with mental
health needs [55].
We were also only able to identify three economic eval-
uations of interventions to encourage physical activity, all
of which focused on depression and or anxiety disorders
rather than also being targeted at people with other severe
mental disorders. There is a need to have more studies fo-
cusing also on addressing physical health promotion in in-
dividuals with severe mental illness, particularly given
their higher risks of metabolic syndrome as a result of
medication use.
This situation may however be changing; two physical
activity related studies in our review were published in
2012 and there are three study protocols looking at the
cost effectiveness of healthy lifestyle promoting interven-
tions, two of which will target people with more severe
mental illness who are being treated in inpatient and
residential settings. A further two study protocols we
identified will look at smoking cessation interventions, in-
cluding one for residents of an acute psychiatric inpatient
care facility.
Overall, most of the studies we identified suggest that
there is an economic case for protecting the physical
health of people with mental health needs, and most re-
port incremental cost effectiveness ratios such as cost per
smoking quit achieved or cost per QALY gained.
Strengthening the literature
There remain substantial limitations and research gaps
with the existing literature. Here we briefly discuss issues
around uptake and behaviour change; population sub-
group analysis; the timeframe of studies; study perspective;
sample size; transferability to different contexts; better un-
derstanding of issues of fidelity in implementation; and
the potential for economic modelling.
Uptake and behaviour change
Firstly, there was little exploration in this analysis of fac-
tors that either inhibit or promote sustained behaviour
change. This is of particular importance when considering
health promoting interventions which require regular be-
haviour change and/or participation in an activity over a
period of time to have an impact, e.g. exercise and diet
programmes. Economic analyses need to consider the ex-
tent to which these uptake issues apply to interventions to
address physical co-morbidity in this population and what
additional costs are incurred as a result of effective mea-
sures taken to promote better uptake [69]. It may well bethe case that interventions that currently do not appear
cost effective may be seen in a more favourable light if re-
sources were invested in better tailoring of programmes
and interventions to people with mental health needs.
This also raises the possibility of looking at the cost ef-
fectiveness of techniques from behavioural psychology or
economics to influence individual behaviour patterns and
perhaps ‘nudge’ people towards different types of behav-
iours. Recent reviews of this literature in respect of people
with mental health problems are tentatively positive
[70,71], requiring further research not only on effective-
ness but also on the costs of implementation.
In this context nurses and other health care professionals
such as physical health and lifestyle trainers that routinely
work closely with people with mental health problems can
focus more on looking at factors that may encourage
greater sustained participation in health promoting activ-
ities [72]. Strengthening the training of professionals in
somatic care, as well as going beyond the absence of men-
tal disorder to consider the benefits of positive wellbeing,
can only be helpful for lifestyle monitoring and behavioural
change [73]. Better training will also reduce the likelihood
that these professionals ‘avoid’ dealing with physical health
issues through a lack of expertise.
Sub-group analyses
It is also important to consider cost effectiveness for
population sub-groups as cost effectiveness ratios for the
population as a whole may not reflect the cost effective-
ness of the intervention for specific population groups, for
instance related to age, gender, diagnosis or living condi-
tions [74]. Few of the studies undertaken to date have
looked at sub-groups, although there can be very different
conclusions drawn on what is cost effective, as in the case
of the evaluation of HIV risk reduction programmes for
men or women [48]. It may also be the case, for example,
that it might be easier to encourage individuals to take up
physical activities when they are living in residential ac-
commodation which includes a gym or other sporting
equipment, compared with individuals who are living in-
dependently in the community and may not have easy ac-
cess to this equipment. In the same way it may be more
challenging for individuals to eat healthily if they are living
in areas with little easy access to fresh fruit and vegetables,
but many fast food restaurants [75]. This is also important
when considering the implications for health inequalities
of any intervention. Health promoting interventions for
the general population can in some circumstances widen
health inequalities within the population because of differ-
ent rates of uptake and capacity to benefit [76].
Study timeframes
We also know comparatively little about the long term ef-
fectiveness and therefore long term cost effectiveness of
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period between three and 12 months. Only three studies
covered longer periods from 18 to 24 months. We have
noted that health promotion interventions may require
regular long term use to ensure sustained behaviour
change, let alone have a sustained impact on physical
health. In a shorter time frame, studies may have to rely
on intermediate outcomes such as abstinence from smok-
ing or harmful drinking or changes in dietary behaviour.
These intermediate indicators may not always immedi-
ately translate into anticipated health gains, although there
may be short term benefits to be flagged up e.g. from so-
cial capital gained through socialisation and networking
with other participants in an exercise class. Economic ana-
lysis should also consider the economic benefits of any
improvements in mental health arising from health pro-
moting interventions.Study perspective
It is also important to consider the impact of study per-
spective on the cost effectiveness. Some of the costs of
health promoting interventions might be borne outside
the health care system, e.g. local government may be re-
sponsible for some aspects of sports and recreation activ-
ities, while there will also be external economic benefits
such a potential reduction in the need for informal care
support from family members and a reduction in time
spent out of work for people of working age. Some of
these broader impacts may make the case for investment
stronger. Better physical health may remove one barrier
to maintaining or gaining a job, improving self-care and
self-management skills, as well as improving quality of
life and sense of social inclusion in the local community.
However most studies we identified focused solely on the
perspective of the health care budget holder alone and
did not consider these broader impacts. Only four studies
looked at costs from a broader viewpoint, including costs
to the criminal justice system [58], the public purse [51]
and the opportunity costs incurred by study participants
[47,48].Sample size
Another challenge is the lack of statistically significant dif-
ferences in costs between interventions and comparators
in a number of studies. This is by no means unique to this
literature, but it means that studies may have been
powered to detect significant differences in effect size be-
tween interventions and control groups, but not any sig-
nificant differences in cost [46,48,49,59,61]. In studies with
small sample sizes, skewed costs driven by a few unusually
costly individuals in one community can also distort po-
tential average cost per participant [59,77].Transferability across contexts
Most studies are concentrated in the US; but regardless of
where a study is set how generalisable are findings to
other contexts? Uptake and use of interventions may be
influenced by the organisation, structure and culture of
health care systems in different countries. Even within a
country, especially where there are significant differences
in structures between regions, e.g. between American
states, cost effectiveness findings on programmes may not
be easily generalisable [59]. In the case of the Spanish
walking for health programme, the high rate of recruit-
ment (79%) had an influence on programme cost effect-
iveness. A low cost intervention, a letter from a general
practitioner sent to women in the target population, was
sufficient to encourage participation in the programme
[49]. In countries where primary care does not play such a
pivotal role, different, potentially more expensive, methods
of engaging with the target population may be required.
It is also important to explicitly report resources used
separately from their costs in order to aid future adapta-
tion of study results [69] [78] and to be aware of the fidel-
ity in the way that programmes have been implemented in
different contexts; a lack of fidelity in complying with
recommended practice protocols meant that Integrated
Assertive Community Treatment was reported to be less
costly than standard Assertive Community Treatment in
one study in our analysis [59].Fidelity in implementation
Process and context evaluation alongside economic ana-
lyses is also crucial to monitor the fidelity in implementa-
tion of interventions. Consultation with experts can be
used to get a sense of the feasibility of delivering an inter-
vention to a minority population group, for example. In
the STIRR programme, cultural competence experts/eth-
nographers, who were specialised in urban, African-
American culture checked any potential cultural issues
with pilot participants from ethnic minority backgrounds
before delivering the intervention to the larger study
population [61]. Discussions with local experts can also
help to identify any potential differences and resource re-
quirements that are likely to be observed when adapting
an intervention to a different context.Using models
Economic models can be used to synthesise data on costs
and benefits; crucially they can be used to project long
term costs and benefits well beyond the duration of any
empirical study. Yet they appear to have been rarely used
for interventions for this client group thus far, although
one of the study protocols identified in this review will
model ten year impacts on cardiovascular disease and dia-
betes of a health promotion intervention [53].
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motion pathways and outcomes can also be adapted in
models to take account of different infrastructure con-
texts, cultural factors or different levels of engagement in
different population groups. Different scenarios can be
constructed to take account of different probabilities of
uptake and participation in population sub-groups, for in-
stance accounting for differences in the severity of symp-
toms for different mental disorders or accommodation
status. Impacts on quality of life and other outcomes can
also be varied in modelling analyses. The potential long
term benefits to health of sustained change in health pro-
moting behaviours can also be projected in models.
Sensitivity analysis with these models can be used to
explore the minimum level of effectiveness that would be
required for an intervention to be cost effective in differ-
ent country contexts. This in turn can help decision
makers determine whether piloting a health promoting
approach developed elsewhere is feasible. Such analyses
might also help in better targeting health promoting in-
terventions, or in adapting them to the needs of different
population sub-groups.Limitations of the review
Although our review was not restricted to English lan-
guage materials, no studies in other languages were identi-
fied. One potential bias may be that we did not search any
non-English language bibliographic databases, nor did we
search for terms in languages other than English. We also
excluded studies such as exercise programmes for people
with mental health problems which at first sight intuitively
appear to be relevant. These were excluded because they
did not report physical health outcomes, however, much
may be learnt on the acceptability of exercise programmes
from these studies. In addition, quite a few economic
evaluation studies excluded were for interventions to pre-
vent and treat infectious diseases such as HIV/AIDS,
hepatitis B and hepatitis C for people with substance
abuse without any official diagnosis of mental illness.
Given the high level of co-morbidity between mental ill-
ness and substance abuse, it may be the case that much
can be learnt from these studies.
We also did not look at the cost effectiveness of any
pharmacological developments that may reduce any risk
of adverse events such as weight gain and metabolic syn-
drome, from antipsychotics or antidepressants. Although
excluded from our analysis, we did identify one such study
[79]. This is an area that also merits further future ana-
lyses, including exploration of combined health promo-
tion/pharmacological interventions. It may also be the
case that useful data from specialist early intervention
teams for mental health may have been overlooked, given
that these teams often include physical health specialists.To date however, economic studies of these teams have
focused on impacts on mental health alone [80].
The small number of studies identified, coupled with
limited diagnostic differentiation, also means that we have
to be very cautious in our interpretation of the findings of
this review. Interventions looking at physical activity and
smoking cessation have been targeted at people with de-
pression and anxiety disorders; the merits of these inter-
ventions in promoting the physical health of people with
other severe mental illness need to be assessed. Equally,
actions to prevent substance abuse and infectious disease
have concentrated on severe mental illness and need to be
explored with other population groups.
Despite these limitations we believe we have conducted
the most comprehensive review to date of economic
evaluations for physical health promotion in people with
mental health problems. Economic evaluations covering
interventions to promote physical activity and better diet-
ary behaviour, discourage smoking, substance and alcohol
consumption and reduce the risk of blood borne disease
specifically in populations with mental health needs, both
within inpatient facilities and in the community, have
been identified.
Conclusions
There is a very small, albeit growing, literature on the cost
effectiveness of interventions to promote the physical
health of people with mental health problems. Most of
these studies suggest that value for money actions in spe-
cific contexts and settings are available. What is clear
however is that as the success or failure of health promot-
ing interventions can be very context specific, more stud-
ies are needed in more settings, reporting outcomes in a
common metric, such as quality of life years gained, and
showing resource use and costs in a transparent manner,
including costs beyond the health care system.
In the short-term, economic modelling techniques
might be better utilised to explore possible costs and ben-
efits under different scenarios and over different time
horizons, making use of a wide range of sensitivity ana-
lyses to account for uncertainty in data parameters. Such
models can synthesise data from existing effectiveness re-
views [40,41]. In the mid to longer term it would be help-
ful to at least collect data on resource use and cost
impacts alongside effectiveness data in new trials. This
can facilitate better comparability across different inter-
ventions and ultimately help policymakers in the public
health arena to prioritise resource allocations to specific
preventive strategies.
Finally it should never be forgotten that economic eval-
uations are not conducted in isolation. Apart from cost-
effectiveness, it is crucial to look at barriers and facilitators
to intervention by being mindful of the findings of any
process evaluation, so as to take into account issues such
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behavioural psychological techniques to influence health
behaviours and mitigate any adverse impact on health in-
equalities might also be considered. Looking at the success
or failure of the organisation of any system to promote
physical health can also be the subject of economic ana-
lysis, for instance in terms of different types of multidis-
ciplinary team work, links between primary and specialist
care services, and in the co-ordination and continuity of
mental and physical health care services.
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